SOURCE: Ingen Technologies Inc.

Ingen Technologies Inc.

June 26, 2012 08:15 ET

Ingen Prepares for a National Distribution Program

32 Million COPD Patients Now Have Easier Access to Ingen's Oxyview Products

RIVERSIDE, CA--(Marketwire - Jun 26, 2012) - Ingen Technologies, Inc. (PINKSHEETS: IGNT), an emerging medical device manufacturer with proprietary products for the growing $4B respiratory markets, announced today that the company has placed its Oxyview product line with a leading national medical supplier for the home healthcare and hospital markets. An announcement will be made at the proper time in the near future.

While the company prepares its annual report ending May 31st, 2012, it is also preparing to finalize a complete reorganization of its distribution program from a "Direct Sales" program to a "National Supplier & Distribution Sales" program. This strategy affords the company to decrease internal costs associated with product marketing and distribution while increasing revenues and consumer access on a national basis. The company will redesign its website so that consumers will have a direct link to this national supplier for all Oxyview product purchases.

Chairman Gary Tilden stated, "Although it has been a difficult 18 months for us, I am very pleased to deliver some good news to our shareholders and customers. Our focus on change and growth has yielded some positive results. Our Oxyview product is proprietary and patented, and was ahead of its time in technology. Now the time has come and large medical suppliers can see the benefits Oxyview offers to the home healthcare market and hospital markets. All of us look forward to a great year ahead of us with this company."


Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

Contact Information